61
Participants
Start Date
December 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
AZLI
AZLI 75 mg was administered 3 times daily via the investigational nebulizer.
SUNY Upstate Medical University, Syracuse
Nemours Children's Clinic - Jacksonville, Jacksonville
Nationwide Children's Hospital, Columbus
Riley Hospital for Children, Indianapolis
Children's Memorial Hospital, Chicago
Children's Mercy Hospital & Clinics, Kansas City
Baylor College of Medicine, Houston
The Children's Hospital - Denver, Aurora
University of Utah, Salt Lake City
Children's Hospital Boston, Boston
C.H.U de Bordeaux, Bordeaux
Centre Hospitalier Robert Bissons, Lisieux
Hopital Necker Enfants Malades, Paris
Charite Campus Virchow Klinikum, Berlin
Universitatsklinik St. Josef-Hospital, Bochum
Kinder und Jugendklinik, Abteilung Lungen Bronchialheikunde, Erlandgen
Universitatsklinikum Essen, Essen
J.W. Goethe University Hopsital, Frankfurt
Azienda Ospedaliero Universitaria - Policlinico di Catania, Catania
A. Meyer Children Hospital Florence, Florence
Azienda Ospedaliera Instituti Ospitalieri di Verona, Verona
Specjalistyczny Zespot Opieki Zdrowotnej nad Matka i Dzieckiem, Gdansk
Instytut Gruzlicy I Chorob Pluc, Rabka-Zdrój
Instytut Matki i Dziecka, Warsaw
Pediatric Pneunmonology and Cystic Fibrosis Clinic, Barcelona
Hospital Infantil La Paz, Madrid
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital Ramon y Cajal, Madrid
Hosp. Mat-Inf. Carlos Haya, Málaga
Lead Sponsor
Gilead Sciences
INDUSTRY